SARS-CoV-2 (variant) detection solutions with the NextGenPCR®
Molecular Biology Systems continuously strives to develop and improve its SARS-CoV-2 PCR products. With our products, we provide laboratories with the necessary tools to help combat the ongoing Covid-19 pandemic. Our experts at the R&D team have developed two unique solutions for SARS-CoV-2 detection and variant surveillance. With our fluorescence probe based screening solution you are able to determine an active SARS-CoV-2 infection directly from a clinical sample within 27 minutes. With our variant Nanopore sequencing solution you can increase your throughput up to 4 times. More information below.